• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA PLT +20ML SAMPLER, MULTIPLS, RBC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA PLT +20ML SAMPLER, MULTIPLS, RBC Back to Search Results
Model Number 82416
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/24/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Investigation: the run data file (rdf) was analyzed for this event.The signals in the run data file indicate that the higher-than-expected wbc content in the platelet product was possibly a result of an escape of wbcs from the lrs chamber during the latter portion of the collection.Additionally, the signals indicate that the device had difficulty reaching steady state from the beginning of the procedure, so it cannot be ruled out that the needle line access may have shifted and could potentially have impacted the draw flow rate.Based on the available information, it also cannot be ruled out that the higher than-expected wbc content in the platelet product could be donor-related.Investigation is in process.A follow-up report will be provided.
 
Event or Problem Description
The customer would like the run data file investigated to determine a possible cause for the elevated white blood cell (wbc) content in the platelet product.There was not a transfusion recipient or patient involved at the time of the residual wbc testing, therefore no patient information is reasonably known at the time of the event.The platelet collection set is not available for return because it was discarded by the customer.
 
Event or Problem Description
The customer would like the run data file investigated to determine a possible cause for the elevated white blood cell (wbc) content in the platelet product.There was not a transfusion recipient or patient involved at the time of the residual wbc testing, therefore no patient information is reasonably known at the time of the event.The platelet collection set is not available for return because it was discarded by the customer.
 
Additional Manufacturer Narrative
Investigation: the run data file (rdf) was analyzed for this event.The signals in the run data file indicate that the higher-than-expected wbc content in the platelet product was possibly a result of an escape of wbcs from the lrs chamber during the latter portion of the collection.Additionally, the signals indicate that the device had difficulty reaching steady state from the beginning of the procedure, so it cannot be ruled out that the needle line access may have shifted and could potentially have impacted the draw flow rate.Based on the available information, it also cannot be ruled out that the higher than-expected wbc content in the platelet product could be donor-related.The device history records (dhr) were reviewed for this lot.There were no events noted in the dhr that would have contributed to the elevated wbc count experienced by the customer.Root cause: the signals in the run data file indicate that the higher-than-expected wbc content in the platelet product was possibly a result of an escape of wbcs from the lrs chamber during the latter portion of the collection.Additionally, the signals indicate that the device had difficulty reaching steady state from the beginning of the procedure, so it cannot be ruled out that the needle line access may have shifted and could potentially have impacted the draw flow rate.Based on the available information, it also cannot be ruled out that the higher-than-expected wbc content in the platelet product could be donor-related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Common Device Name
TRIMA PLT +20ML SAMPLER, MULTIPLS, RBC
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key12488763
Report Number1722028-2021-00303
Device Sequence Number17433171
Product Code GKT
UDI-Device Identifier05020583824164
UDI-Public05020583824164
Combination Product (Y/N)N
Initial Reporter StateHI
Initial Reporter CountryUS
PMA/510(K) Number
BK190332
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date (Section B) 09/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/01/2023
Device Model Number82416
Device Catalogue Number3824162
Device Lot Number2105252232
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/25/2021
Supplement Date Received by Manufacturer11/11/2021
Initial Report FDA Received Date09/17/2021
Supplement Report FDA Received Date11/29/2021
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/27/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-